John Forrest - Spire Healthcare Chief Officer
| SPI Stock | 225.50 6.00 2.73% |
Executive
John Forrest is Chief Officer of Spire Healthcare Group
| Address | 3 Dorset Rise, London, United Kingdom, EC4Y 8EN |
| Phone | 44 20 7427 9000 |
| Web | https://www.spirehealthcare.com |
Spire Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.0373 % which means that it generated a profit of $0.0373 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.04 %, meaning that it generated $0.04 on every $100 dollars invested by stockholders. Spire Healthcare's management efficiency ratios could be used to measure how well Spire Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At present, Spire Healthcare's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 254.7 M, whereas Non Current Assets Total are forecasted to decline to about 2 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Robert Schifellite | Broadridge Financial Solutions | 66 | |
| Nick Behan | Norman Broadbent Plc | N/A | |
| Kurt Eldridge | Broadridge Financial Solutions | N/A | |
| Amanda Harper | Norman Broadbent Plc | N/A | |
| Brad Lich | Eastman Chemical Co | 56 | |
| Vincent Roux | Broadridge Financial Solutions | N/A | |
| William Truchy | Kaufman Et Broad | N/A | |
| Adrian Holt | Eastman Chemical Co | 55 | |
| Tyler Derr | Broadridge Financial Solutions | N/A | |
| Sebastien Daveau | X FAB Silicon Foundries | 49 | |
| Jonathan Stringer | Norman Broadbent Plc | N/A | |
| James Peskett | Norman Broadbent Plc | N/A | |
| Jocelyne Wasselin | X FAB Silicon Foundries | 65 | |
| Travis Smith | Eastman Chemical Co | N/A | |
| Hope Jarkowski | Broadridge Financial Solutions | 49 | |
| Thomas Carey | Broadridge Financial Solutions | 53 | |
| Daniel Cwenar | Broadridge Financial Solutions | N/A | |
| Sylvre Hamel | Kaufman Et Broad | N/A | |
| Michael Liberatore | Broadridge Financial Solutions | 58 | |
| Lloyd Whetzel | X FAB Silicon Foundries | 66 | |
| Bob Santangelo | Broadridge Financial Solutions | N/A | |
Management Performance
| Return On Equity | 0.04 | ||||
| Return On Asset | 0.0373 |
Spire Healthcare Leadership Team
Elected by the shareholders, the Spire Healthcare's board of directors comprises two types of representatives: Spire Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spire. The board's role is to monitor Spire Healthcare's management team and ensure that shareholders' interests are well served. Spire Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spire Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angus Prentice, Interim Relations | ||
| Pr Grant, Group Nurse | ||
| Justin BA, CEO Director | ||
| Justinian BA, CEO Director | ||
| Cathy Cale, Group Director | ||
| Philip Davies, Company Secretary | ||
| John Forrest, Chief Officer | ||
| Shelley Thomas, Group Director | ||
| Rachel King, Group Director | ||
| Mathew Mason, Head Purchasing | ||
| Harbant Samra, CFO Director | ||
| Mantraraj Budhdev, Company Counsel | ||
| Jitesh Sodha, CFO Director | ||
| Peter Corfield, Chief Officer | ||
| Derrick Farrell, CEO Group |
Spire Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Spire Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.04 | ||||
| Return On Asset | 0.0373 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 2.12 B | ||||
| Shares Outstanding | 402.85 M | ||||
| Shares Owned By Insiders | 34.00 % | ||||
| Shares Owned By Institutions | 49.96 % | ||||
| Price To Book | 1.23 X | ||||
| Price To Sales | 0.63 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Spire Stock
Spire Healthcare financial ratios help investors to determine whether Spire Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spire with respect to the benefits of owning Spire Healthcare security.